INOVIO PHARMACEUTICALS INC's ticker is INO and the CUSIP is 45773H102. A total of 54 filers reported holding INOVIO PHARMACEUTICALS INC in Q4 2013. The put-call ratio across all filers is - and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q4 2013 | $725,000 | – | 250,000 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Knoll Capital Management, LLC | 408,352 | $1,167,000 | 0.59% |
| CORRADO ADVISORS, LLC | 32,000 | $93,000 | 0.04% |
| Verition Fund Management LLC | 41,573 | $121,000 | 0.02% |
| COHEN LAWRENCE B | 10,000 | $29,000 | 0.02% |
| Tower Research Capital LLC (TRC) | 40,775 | $119,000 | 0.02% |
| WealthTrust Axiom LLC | 10,000 | $29,000 | 0.01% |
| Cambridge Investment Research Advisors, Inc. | 90,250 | $262,000 | 0.01% |
| VSR Financial Services, Inc. | 30,000 | $88,000 | 0.01% |
| Quantitative Investment Management, LLC | 17,700 | $51,000 | 0.01% |
| BRIDGEWAY CAPITAL MANAGEMENT, LLC | 30,000 | $87,000 | 0.00% |